449 related articles for article (PubMed ID: 15471969)
1. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells.
Pak TR; Chung WC; Lund TD; Hinds LR; Clay CM; Handa RJ
Endocrinology; 2005 Jan; 146(1):147-55. PubMed ID: 15471969
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-beta mediates dihydrotestosterone-induced stimulation of the arginine vasopressin promoter in neuronal cells.
Pak TR; Chung WC; Hinds LR; Handa RJ
Endocrinology; 2007 Jul; 148(7):3371-82. PubMed ID: 17412808
[TBL] [Abstract][Full Text] [Related]
3. The androgen metabolite, 5α-androstane-3β,17β-diol (3β-diol), activates the oxytocin promoter through an estrogen receptor-β pathway.
Hiroi R; Lacagnina AF; Hinds LR; Carbone DG; Uht RM; Handa RJ
Endocrinology; 2013 May; 154(5):1802-12. PubMed ID: 23515287
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta selective ligand 5alpha-Androstane-3beta, 17beta-diol stimulates spermatogonial deoxyribonucleic acid synthesis in rat seminiferous epithelium in vitro.
Wahlgren A; Svechnikov K; Strand ML; Jahnukainen K; Parvinen M; Gustafsson JA; Söder O
Endocrinology; 2008 Jun; 149(6):2917-22. PubMed ID: 18292193
[TBL] [Abstract][Full Text] [Related]
5. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA
Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852
[TBL] [Abstract][Full Text] [Related]
6. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
[TBL] [Abstract][Full Text] [Related]
7. An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth.
Weihua Z; Lathe R; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13589-94. PubMed ID: 12370428
[TBL] [Abstract][Full Text] [Related]
8. Effects of CYP7B1-mediated catalysis on estrogen receptor activation.
Pettersson H; Lundqvist J; Norlin M
Biochim Biophys Acta; 2010 Sep; 1801(9):1090-7. PubMed ID: 20553962
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
12. Expression of androgen and estrogen receptors in sertoli cells: studies using the mouse SK11 cell line.
Sneddon SF; Walther N; Saunders PT
Endocrinology; 2005 Dec; 146(12):5304-12. PubMed ID: 16166216
[TBL] [Abstract][Full Text] [Related]
13. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
Pérez-Palacios G; Santillán R; García-Becerra R; Borja-Cacho E; Larrea F; Damián-Matsumura P; González L; Lemus AE
J Endocrinol; 2006 Sep; 190(3):805-18. PubMed ID: 17003281
[TBL] [Abstract][Full Text] [Related]
14. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
15. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus.
Lund TD; Hinds LR; Handa RJ
J Neurosci; 2006 Feb; 26(5):1448-56. PubMed ID: 16452668
[TBL] [Abstract][Full Text] [Related]
16. Activity of estradiol and selective estrogen receptor modulators in the mouse N20.1 oligodendrocyte/astrocytes cell line.
Guzmán CB; Deighton-Collins S; Martinez A; Kleerekoper M; Zhao C; Benjamins JA; Skafar DF
Neuro Endocrinol Lett; 2005 Oct; 26(5):526-32. PubMed ID: 16264406
[TBL] [Abstract][Full Text] [Related]
17. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
[TBL] [Abstract][Full Text] [Related]
18. An estrogenic effect of 5alpha-androstane-3beta, 17beta-diol on the behavioral response to stress and on CRH regulation.
Huang Q; Zhu H; Fischer DF; Zhou JN
Neuropharmacology; 2008 Jun; 54(8):1233-8. PubMed ID: 18457850
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of tyrosine hydroxylase by estrogen: opposite effects with estrogen receptors alpha and beta and interactions with cyclic AMP.
Maharjan S; Serova L; Sabban EL
J Neurochem; 2005 Jun; 93(6):1502-14. PubMed ID: 15935066
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal dynamics of the expression of estrogen receptors in the postnatal mouse brain.
Sugiyama N; Andersson S; Lathe R; Fan X; Alonso-Magdalena P; Schwend T; Nalvarte I; Warner M; Gustafsson JA
Mol Psychiatry; 2009 Feb; 14(2):223-32, 117. PubMed ID: 18982005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
